Gentian Diagnostics ASA Logo

Gentian Diagnostics ASA

Develops and markets in vitro diagnostic reagents for human and veterinary use.

GENT | OL

Overview

Corporate Details

ISIN(s):
NO0010748866
LEI:
5967007LIEEXZXHNM861
Country:
Norway
Address:
Bjørnåsveien 5, 1596 Moss

Description

Gentian Diagnostics ASA is a medical diagnostics company that develops, manufactures, and markets innovative in vitro diagnostic (IVD) reagents. The company specializes in turbidimetric immunoassays designed for open clinical chemistry platforms, aiming to enhance laboratory efficiency and support better clinical treatment decisions. Its portfolio and pipeline of diagnostic tests address biomarkers in high-impact medical areas, including kidney disease, cardiac disease, inflammation, and infection. Key products include assays for Cystatin C, NGAL, and Calprotectin. In addition to its human diagnostics portfolio, the company provides diagnostic solutions for the veterinary market. Gentian serves a global customer base through original equipment manufacturer (OEM) partners, distributors, and healthcare providers.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-01-20 17:51
Notice of extraordinary general meeting
English 203.9 KB
2017-01-20 17:51
Notice of extraordinary general meeting
English 207.3 KB
2017-01-20 17:51
Notice of extraordinary general meeting
English 795 bytes
2017-01-20 13:16
Mandatory notification of trade of primary insider
English 2.5 KB
2017-01-20 07:00
PRIVATE PLACEMENT - BOOKBUILDING IN TRANCHE 1 SUCCESSFULLY COMPLETED - APPLICAT…
English 6.8 KB
2017-01-19 15:30
GENTIAN DIAGNOSTICS - CONTEMPLATED PRIVATE PLACEMENT
English 6.9 KB
2016-12-19 14:31
Gentian Diagnostics AS - Meldepliktig handel
Norwegian 689 bytes
2016-12-16 13:16
Corr* Oslo Børs - GENT-ME - New company admitted to trading on Merkur Market 14…
English 970 bytes
2016-12-16 13:16
Korr* Oslo Børs - GENT-ME - Nytt selskap tas opp til handel på Merkur Market 14…
Norwegian 970 bytes
2016-12-16 13:02
Mandatory notification of trade of primary insider
English 728 bytes
2016-12-14 07:20
Corr* Oslo Børs - GENT-ME - New company admitted to trading on Merkur Market 14…
English 1010 bytes
2016-12-13 14:38
Financial calendar
English 614 bytes
2016-12-13 14:23
Oslo Børs - GENT-ME - New company admitted to trading on Merkur Market 14.12.20…
English 997 bytes
2016-12-13 14:22
Korr* Oslo Børs - GENT-ME - Nytt selskap tas opp til handel på Merkur Market 14…
Norwegian 1023 bytes
2016-12-13 13:35
Approved Admission Document
English 3.9 MB

Automate Your Workflow. Get a real-time feed of all Gentian Diagnostics ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Gentian Diagnostics ASA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Gentian Diagnostics ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cardiol Therapeutics Inc. Logo
Clinical-stage company developing anti-inflammatory and anti-fibrotic heart therapies.
United States of America
CRDL
CAREGEN CO.,LTD. Logo
Develops biomimetic peptides and growth factors for aesthetic and medical solutions.
South Korea
214370
Caribou Biosciences, Inc. Logo
Clinical-stage biopharma developing genome-edited allogeneic cell therapies.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
A clinical-stage biotech developing engineered macrophage-based therapeutics for cancer.
United States of America
CARM
Carna Biosciences, Inc. Logo
Clinical-stage biopharma developing small molecule kinase inhibitors.
Japan
4572
Cartesian Therapeutics, Inc. Logo
A clinical-stage company developing mRNA-engineered cell therapies for autoimmune diseases.
United States of America
RNAC
CASI Pharmaceuticals, Inc. Logo
Biopharmaceutical firm developing therapeutics for organ transplant and autoimmune diseases.
United States of America
CASI
CATALYST PHARMACEUTICALS, INC. Logo
Biopharmaceutical company commercializing drugs for rare neurological and autoimmune diseases.
United States of America
CPRX
cbdMD, Inc. Logo
Producer and distributor of health and wellness CBD products from U.S.-grown hemp.
United States of America
YCBD
CDT Equity Inc. Logo
A clinical-stage biopharmaceutical firm advancing assets for unmet medical needs.
United States of America
CDT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.